The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The microenvironment of pituitary adenomas: biological, clinical and therapeutical implications
Authors
Keywords
-
Journal
Pituitary
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-23
DOI
10.1007/s11102-022-01211-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression
- (2021) Yu Mei et al. Pituitary
- Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma
- (2021) Jing Guo et al. Frontiers in Genetics
- Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
- (2021) Ding Nie et al. World Journal of Surgical Oncology
- Tumor Microenvironment in Breast Cancer—Updates on Therapeutic Implications and Pathologic Assessment
- (2021) Joshua J. Li et al. Cancers
- The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours
- (2021) Pedro Marques et al. JOURNAL OF NEUROENDOCRINOLOGY
- Tumor-Associated Macrophages: New Horizons for Pituitary Adenoma Researches
- (2021) Changxi Han et al. Frontiers in Endocrinology
- The Upregulation of Molecules Related to Tumor Immune Escape in Human Pituitary Adenomas
- (2021) Zhiyu Xi et al. Frontiers in Endocrinology
- Targeting Aggressive Pituitary Adenomas at the Molecular Level—A Review
- (2021) Benjamin Voellger et al. Journal of Clinical Medicine
- Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors
- (2020) Pedro Marques et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pituitary-Tumor Endocrinopathies
- (2020) Shlomo Melmed NEW ENGLAND JOURNAL OF MEDICINE
- How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
- (2020) Jacqueline Trouillas et al. Cancers
- Expression of programmed death-ligand 1 (PD-L1) in human pituitary neuroendocrine tumor
- (2020) Valentine Suteau et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms
- (2020) Vinaya Srirangam Nadhamuni et al. ENDOCRINE REVIEWS
- MSH6/2 and PD-L1 Expressions Are Associated with Tumor Growth and Invasiveness in Silent Pituitary Adenoma Subtypes
- (2020) Shinsuke Uraki et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- In silico analysis of the immunological landscape of pituitary adenomas
- (2020) Jacky T. Yeung et al. JOURNAL OF NEURO-ONCOLOGY
- The tumour microenvironment of pituitary neuroendocrine tumours
- (2020) Pedro Marques et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Immune Landscape of Pituitary Neuroendocrine Tumours Reveals Association between Macrophages and Gonadotroph-Tumour Invasion
- (2020) Moitza Principe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Immune Profile of Pituitary Adenomas and a Novel Immune Classification for Predicting Immunotherapy Responsiveness
- (2020) Zihao Wang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Immunotherapy in Corticotroph and Lactotroph Aggressive Tumors and Carcinomas: Two Case Reports and a Review of the Literature
- (2020) Camille Duhamel et al. Journal of Personalized Medicine
- Update on the Genetics of Pituitary Tumors
- (2020) Sayka Barry et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Immune Checkpoint Inhibitor Therapy for ACTH-Secreting Pituitary Carcinoma: a new emerging treatment?
- (2020) Bastiaan Sol et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comprehensive analysis of the immunological landscape of pituitary adenomas: implications of immunotherapy for pituitary adenomas
- (2020) Wenjianlong Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
- (2020) Italia Falcone et al. Cancers
- The Progress of Immunotherapy in Refractory Pituitary Adenomas and Pituitary Carcinomas
- (2020) Congxin Dai et al. Frontiers in Endocrinology
- Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study
- (2020) Nazanin Majd et al. Journal for ImmunoTherapy of Cancer
- Biomarker Discovery for Immunotherapy of Pituitary Adenomas: Enhanced Robustness and Prediction Ability by Modern Computational Tools
- (2019) Qingxia Yang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Stratifying nonfunctional pituitary adenomas into two groups distinguished by macrophage subtypes
- (2019) Garima Yagnik et al. Oncotarget
- Tumor microenvironment defines the invasive phenotype of AIP-mutation-positive pituitary tumors
- (2019) Sayka Barry et al. ONCOGENE
- E-cadherin expression is associated with somatostatin analogue response in acromegaly
- (2019) Eva Venegas-Moreno et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Surgery, octreotide, temozolomide, bevacizumab, radiotherapy and pegvisomant treatment of an AIP mutation positive child
- (2019) Pinaki Dutta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
- (2019) Mizuto Sato et al. Journal of Clinical Medicine
- Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors
- (2019) Marijo Bilusic et al. Journal for ImmunoTherapy of Cancer
- Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
- (2019) Mario Caccese et al. ANTI-CANCER DRUGS
- Targeting PD-L1 initiates effective anti-tumor immunity in a murine model of Cushing's Disease
- (2019) Hanna R Kemeny et al. CLINICAL CANCER RESEARCH
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
- (2019) Mirela Diana Ilie et al. Cancers
- Pangenomic Classification of Pituitary Neuroendocrine Tumors
- (2019) Mario Neou et al. CANCER CELL
- Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
- (2019) Pedro Marques et al. ENDOCRINE-RELATED CANCER
- Definition and diagnosis of aggressive pituitary tumors
- (2019) Leandro Kasuki et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Functions and mechanisms of tumor necrosis factor-α and noncoding RNAs in bone-invasive pituitary adenomas
- (2018) Haibo Zhu et al. CLINICAL CANCER RESEARCH
- The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes
- (2018) Matthew P. Salomon et al. CLINICAL CANCER RESEARCH
- The expression profile of PD-L1 and CD8+ lymphocyte in pituitary adenomas indicating for immunotherapy
- (2018) Peng-fei Wang et al. JOURNAL OF NEURO-ONCOLOGY
- Landscape of Molecular Events in Pituitary Apoplexy
- (2018) Prakamya Gupta et al. Frontiers in Endocrinology
- Marked response of a hypermutated adrenocorticotropic hormone-secreting pituitary carcinoma to ipilimumab and nivolumab
- (2018) Andrew L Lin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Imatinib Inhibits GH Secretion From Somatotropinomas
- (2018) Prakamya Gupta et al. Frontiers in Endocrinology
- A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion
- (2018) Feng Cai et al. World Neurosurgery
- The role of the tumour microenvironment in immune therapy
- (2017) Stephan Gasser et al. ENDOCRINE-RELATED CANCER
- Genetic Aspects of Pituitary Adenomas
- (2017) Pedro Marques et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Invasive Pituitary Adenoma-Derived Tumor-Associated Fibroblasts Promote Tumor Progression both In Vitro and In Vivo
- (2017) Liang Lv et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Trophic and neurotrophic factors in human pituitary adenomas (Review)
- (2017) Marialuisa Spoletini et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Growth Hormone and the Epithelial-to-Mesenchymal Transition
- (2017) Alison L Brittain et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- AIP and the somatostatin system in pituitary tumours
- (2017) Alejandro Ibáñez-Costa et al. JOURNAL OF ENDOCRINOLOGY
- Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis
- (2017) Timothy E. Richardson et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Novel Genetic Causes of Pituitary Adenomas
- (2016) F. Caimari et al. CLINICAL CANCER RESEARCH
- Significance of TNF-α and IL-6 expression in invasive pituitary adenomas
- (2016) J.L. Wu et al. GENETICS AND MOLECULAR RESEARCH
- Alterations of collagen-producing cells in human pituitary adenomas
- (2016) Alimuddin Tofrizal et al. Medical Molecular Morphology
- Integrative proteomics and transcriptomics revealed that activation of the IL-6R/JAK2/STAT3/MMP9 signaling pathway is correlated with invasion of pituitary null cell adenomas
- (2016) Jie Feng et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line
- (2016) Takashi Fukuda et al. PLoS One
- Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts
- (2016) Siham Moatassim-Billah et al. Oncotarget
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancer-associated fibroblasts abrogates pancreatic tumour chemoresistance
- (2015) C. Duluc et al. EMBO Molecular Medicine
- Immune Cell Infiltrates in Pituitary Adenomas: More Macrophages in Larger Adenomas and More T Cells in Growth Hormone Adenomas
- (2015) Jian-Qiang Lu et al. ENDOCRINE PATHOLOGY
- Pituitary Tumors
- (2015) Shlomo Melmed ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon
- (2015) Qinjie Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas
- (2015) M Victoria Recouvreux et al. JOURNAL OF ENDOCRINOLOGY
- Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation
- (2015) Mara L. Lennard Richard et al. MOLECULAR IMMUNOLOGY
- Aryl hydrocarbon receptor: Linking environment to immunity
- (2015) Marina Cella et al. SEMINARS IN IMMUNOLOGY
- Pituitary Adenoma and the Chemokine Network: A Systemic View
- (2015) Fabio Grizzi et al. Frontiers in Endocrinology
- Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth
- (2015) Kazuyoshi Shiga et al. Cancers
- The Aryl Hydrocarbon Receptor: Multitasking in the Immune System
- (2014) Brigitta Stockinger et al. Annual Review of Immunology
- The Fli-1 Transcription Factor Regulates the Expression of CCL5/RANTES
- (2014) Mara L. Lennard Richard et al. JOURNAL OF IMMUNOLOGY
- Epidemiology and etiopathogenesis of pituitary adenomas
- (2014) Elena D. Aflorei et al. JOURNAL OF NEURO-ONCOLOGY
- Mutations in the deubiquitinase gene USP8 cause Cushing's disease
- (2014) Martin Reincke et al. NATURE GENETICS
- Aggressive pituitary adenomas—diagnosis and emerging treatments
- (2014) Antonio Di Ieva et al. Nature Reviews Endocrinology
- The ets transcription factor Fli-1 in development, cancer and disease
- (2014) Y Li et al. ONCOGENE
- Angiogenesis in Pituitary Adenomas: Human Studies and New Mutant Mouse Models
- (2014) Carolina Cristina et al. International Journal of Endocrinology
- A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors
- (2013) Shahneen K. Sandhu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
- (2013) Albert Beckers et al. ENDOCRINE REVIEWS
- The roles of aryl hydrocarbon receptor in immune responses
- (2013) Nam Trung Nguyen et al. INTERNATIONAL IMMUNOLOGY
- The tumor microenvironment at a glance
- (2013) F. R. Balkwill et al. JOURNAL OF CELL SCIENCE
- Tumour suppressor gene function in carcinoma-associated fibroblasts: from tumour cells via EMT and back again?
- (2013) Lauren E Drake et al. JOURNAL OF PATHOLOGY
- Expression of T-helper-associated cytokines in the serum of pituitary adenoma patients preoperatively and postperatively
- (2013) Lubin Qiu et al. MEDICAL HYPOTHESES
- Gene Expression Profiling Identifies ESRP1 as a Potential Regulator of Epithelial Mesenchymal Transition in Somatotroph Adenomas from a Large Cohort of Patients with Acromegaly
- (2012) Tove Lekva et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cellular and Molecular Specificity of Pituitary Gland Physiology
- (2012) Carolina Perez-Castro et al. PHYSIOLOGICAL REVIEWS
- Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence
- (2012) Ruth Sánchez-Ortiga et al. Pituitary
- Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression
- (2011) Paolo Cirri et al. CANCER AND METASTASIS REVIEWS
- Interleukin-8 production from human somatotroph adenoma cells is stimulated by interleukin-1β and inhibited by growth hormone releasing hormone and somatostatin
- (2011) Signe Diness Vindeløv et al. GROWTH HORMONE & IGF RESEARCH
- In Nonfunctional Pituitary Adenomas, Estrogen Receptors and Slug Contribute to Development of Invasiveness
- (2011) Wei Zhou et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The chemokine system and cancer
- (2011) Frances R Balkwill JOURNAL OF PATHOLOGY
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Pathogenesis of pituitary tumors
- (2011) Shlomo Melmed Nature Reviews Endocrinology
- The expression of interleukin (IL)-17 and IL-17 receptor and MMP-9 in human pituitary adenomas
- (2011) Lubin Qiu et al. Pituitary
- Cancer-related inflammation: Common themes and therapeutic opportunities
- (2011) Frances R. Balkwill et al. SEMINARS IN CANCER BIOLOGY
- The Cyclic Pentapeptide d-Arg3FC131, a CXCR4 Antagonist, Induces Apoptosis of Somatotrope Tumor and Inhibits Tumor Growth in Nude Mice
- (2010) Jeong Mo Kim et al. ENDOCRINOLOGY
- Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
- (2010) Federica Marchesi et al. JOURNAL OF NEUROIMMUNOLOGY
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- The chemokine system in cancer biology and therapy
- (2009) Alberto Mantovani et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-6 is an autocrine growth factor for folliculostellate-like TtT/GF mouse pituitary tumor cells
- (2009) U. Renner et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Regulation of Pituitary Function by Cytokines
- (2009) Mariana R. Haedo et al. HORMONE RESEARCH
- Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma
- (2009) Isabella Lupi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Multiphoton Imaging and Quantitative Analysis of Collagen Production by Chondrogenic Human Mesenchymal Stem Cells Cultured in Chitosan Scaffold
- (2009) Wei-Liang Chen et al. TISSUE ENGINEERING PART C-METHODS
- Overexpression of Stromal Cell-Derived Factor 1 and Its Receptor CXCR4 Induces Autocrine/Paracrine Cell Proliferation in Human Pituitary Adenomas
- (2008) F. Barbieri et al. CLINICAL CANCER RESEARCH
- Tumor-host interactions: the role of inflammation
- (2008) Marie-Aude Bitoux et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Functional expression of CXCR4 in somatotrophs: CXCL12 activates GH gene, GH production and secretion, and cellular proliferation
- (2008) Yongho Lee et al. JOURNAL OF ENDOCRINOLOGY
- An Insight to Pituitary Folliculo-Stellate Cells
- (2008) S. Devnath et al. JOURNAL OF NEUROENDOCRINOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- Regulatory T cells and the PD-L1/PD-1 pathway mediate immune suppression in malignant human brain tumors
- (2008) Joannes F.M. Jacobs et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started